ALPS BIOSCIENCES LIMITED
Opportunity 70/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (58/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-05-31 | 2024-05-31 |
|---|---|---|
| Average employees | 200 | 100 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
Corporate timeline (18 events)Click to expand
- 2025-09-22📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-09-01📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-04-17📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2025-04-08📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2025-03-28📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2025-02-25📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-08-01📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2024-06-07📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2024-06-07📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2024-03-15📄accounts-with-accounts-type-dormantaccounts · AA
- 2023-05-25📄accounts-with-accounts-type-dormantaccounts · AA
- 2022-02-23📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2022-02-23📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2022-02-23📄accounts-with-accounts-type-dormantaccounts · AA
- 2021-05-26📄accounts-with-accounts-type-dormantaccounts · AA
- 2020-02-28📄accounts-with-accounts-type-dormantaccounts · AA
- 2017-05-04🏢Company incorporatedAs ALPS BIOSCIENCES LIMITED
- 2017-05-04➕PATEL, Umang Rajendrakumar appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +No director turnover: Company is 9 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
1 lowMultiple address changes in a short period can indicate operational instability or admin disorder.
Group structure
Lewis Pharmaceuticals Private Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
2 active beneficial owners · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Lewis Pharmaceuticals Private Limited Corporate entity | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 28/03/2025 |
Mr Umang Rajendrakumar Patel Individual · Indian · DOB 08/1991 · age 35 | 75–100% | 75–100% | board controlsig. influence75-100% shares · 75-100% voting · board control · significant influence · firm interest | 04/05/2017 |
3 historic (ceased) PSCs
- Mr Umang Rajendrakumar Patelceased 28/03/2025· 75-100% shares · 75-100% voting · board control
- Lewis Pharmaceuticals Private Limitedceased 07/06/2024· 75-100% shares · 75-100% voting · board control
- Mr Umang Rajendrakumar Patelceased 22/02/2022· 75-100% shares · 75-100% voting · board control
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Manufacturing · TW postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ALPEN TOUCH LTD→ 16685926 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ALTUS SHOPFITTERS LTD→ 13259763 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| AMAC BOAT REPAIRS LTD→ 10915555 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AMATRON LIMITED→ 11954064 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AMBERLEY GROUP LTD→ 08106342 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| AMIROSERVICE1 LIMITED→ 17020762 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AMOCO U.K.PETROLEUM LIMITED→ 00799710 · est 1964 · no financials extracted | — | — | — | — | 62y | — | — |
| AMORPHOUS TECHNOLOGIES AND ENGINEERING LTD→ 15527657 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AMR TELECOM LIMITED→ 10260118 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| ANA DE SA LTD→ 17076541 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ANANTAA AVIATION LIMITED→ 15512910 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ANCO LTD→ 15458980 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.